oxybutynin

(redirected from Oxytrol)
Also found in: Medical.

ox·y·bu·ty·nin

 (ŏk′sē-byo͞ot′n-ĭn)
n.
An anticholinergic drug, C22H31NO3, used to treat incontinence and other urinary symptoms.

[oxy- + but- + -yn(e) + -in.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

oxybutynin

n oxibutinina
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Recent examples include Oxytrol for Women (Merck) for the O-T-C treatment of overactive bladder; Nasacort 24HR (Sanofi) intranasal steroid for the treatment of allergies; and two intranasal steroid switches, Flonase Allergy Relief (GlaxoSmithKline) and Rhinocort Allergy Spray (Johnson & Johnson).
A few years ago, she was the lead project manager and consultant on the switch of Oxytrol for Merck.
The bladder control drug oxybutynin, which was partially switched in 2013 as an OTC transdermal patch marketed by Merck as Oxytrol for Women, is another drug that's being discussed.
"These are Oxytrol for Women (Merck) in September 2013 for the O-T-C treatment of overactive bladder and Nasacort 24HR (Sanofi) intranasal steroid for the treatment of allergies in 2014.
According to Actavis, for the non-generic business, the firm will continue to promote and distribute branded medicines in the range including but not limited to products such as Actonel and Oxytrol. The Irish company will also continue to provide Botox, eye-care products and all other heritage Allergan products.
Importantly, for the non-generic business, Actavis will continue to promote and distribute branded medicines in the portfolio including but not limited to products such as Actonel and Oxytrol.
Drugs known as anticholinergics (such as Ditropan, Detrol, Vesicare, Enablex, Gelnique, Oxytrol and Toviaz) suppress involuntary bladder contractions to help with urgency, frequency and urgency-related leakage.
The Oxytrol patch, previously a prescription-only drug, will become available this fall as an over-the-counter product for women with that condition.
In January, the FDA approved an over-the-counter oxybutynin patch (Oxytrol) for use in women with OAB.
Oxybutynin is available in tablets (Ditropan), extended-release tablets (Ditropan XL), patch (Oxytrol) and gel form (Gelnique).
On Friday, Oxytrol was approved for use by women over the age of 18.
Oxybutynin is available in a transdermal patch, but only as a trade formulation (Oxytrol), which does not include any pediatric information on the label other than that safety and efficacy in pediatric patients has not been established.